SHPH
Shuttle Pharmaceuticals Holdings, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website uttlepharma.com
- Employees(FY) 7
- ISIN US8256932034
Performance
+24.5%
1W
+35.36%
1M
+39.33%
3M
+9.35%
6M
+16.7%
YTD
-52.19%
1Y
Profile
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Technical Analysis of SHPH 2024-05-31
Overview:
In analyzing the technical indicators for SHPH over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-22 04:15
- 2024-05-13 21:00
Shuttle Pharma Provides First Quarter 2024 Corporate Update(Globenewswire)
- 2024-05-13 09:53
- 2024-04-28 21:00
- 2024-04-23 04:15
- 2024-04-02 21:00
- 2024-04-02 19:00
- 2024-04-01 19:00
- 2024-03-21 21:00
- 2024-03-05 18:00
- 2024-03-04 20:00
- 2024-03-04 18:00
- 2024-02-12 19:00
- 2024-01-23 03:30
- 2024-01-07 20:00
- 2023-12-10 20:00
- 2023-12-05 18:00
- 2023-12-04 18:00
- 2023-11-29 20:00
- 2023-11-13 20:00
- 2023-10-30 21:00
- 2023-10-09 21:00
- 2023-09-24 21:00
- 2023-09-12 21:00
- 2023-09-10 21:00
- 2023-08-28 21:00
- 2023-08-14 21:00
- 2023-08-02 21:00
- 2023-05-25 21:00
- 2023-05-16 21:00
Page 1 of 2
previousnext